AIM ImmunoTech Inc. (NYSE American: AIM) (“AIM” or the “Company”) today announced that the United States Patent and Trademark Office has granted a patent covering the use of the Company's drug ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results